Navigation Links
Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
Date:1/21/2008

MADISON, Wis., Jan. 21 /PRNewswire/ -- While urinary stents and catheters can be life-saving medical devices, 40 percent of patients end up with bacterial infections. With 100 million placed in patients each year, this means that doctors must treat 40 million device-associated infections annually. Nerites Corporation is testing its unique new technology for preventing these dangerous infections, with funding from a $100,000 small business innovation research grant (SBIR) from the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health (NIH).

The study will determine whether Nerites novel polymer coatings can prevent biofilm growth, the source of most infections on urinary stents and catheters. Biofilms grow on the surface of the device and provide an anchor for bacteria, which then recruit other bacteria and cause infection.

"Current methods to prevent biofilms are expensive, often ineffective and can promote antibiotic resistance," said Thomas J. Mozer, Ph.D., CEO and President of Nerites Corporation. "This money will help us test our coating technology, which we believe will block biofilm formation reliably and inexpensively, without antibiotics or biocides."

About Nerites: Nerites Corporation develops novel tissue repair products as well as advanced coatings for implanted medical devices and device uses on skin based on unique "wet" adhesive compounds. These synthetic compounds are based upon research by Dr. Phil Messersmith at Northwestern University's Department of Biomedical Engineering on how marine mussels bind to surfaces underwater, are a breakthrough advance in biologically-compatible adhesives that provide completely new options for tissue repair, skin adhesives, and device coatings. Nerites is based in Madison Wisconsin. (http://www.nerites.com)


'/>"/>
SOURCE Nerites Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
2. MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS
3. Novadaqs SPY System receives clearance for use in organ transplant surgery
4. BeneChills RhinoChill System Receives CE Marking for European Commercial Sale
5. e-Health Card Terminal From SCM Microsystems Receives GEMATIK Certification
6. Breckenridge Pharmaceutical Settles Paragraph IV Litigation and Receives FDA Approval for its Oxcarbazepine ANDA
7. LifeMasters Receives Full URAC Disease Management Accreditation
8. Federal Government Receives Failing Grades on Tobacco Control in Annual American Lung Association Report
9. Glory Foods Receives Heart Healthy Certification
10. TeamStaff Receives Nasdaq Determination Letter
11. Gary Tschautscher of Nonin Medical, Inc. Receives CEO of 2007 for North American Patient Monitoring From Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... American ... chief medical officer of Blue Horizon International (BHI), Brian Mehling, M.D., spoke at ... held during May 5-6, 2016 in Chicago, IL, USA. Dr. Mehling’s presentation was ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... and products recently hosted the first PowerWave Instructor Certification Course in Stoughton, Massachusetts. ... a group of fitness professional through the 8 hour interactive course to qualify ...
(Date:5/26/2016)... ... May 26, 2016 , ... On May 23rd during ... Water Life Science® and international water advocate, was honored by Ashram, Inc. as the ... ancient Egypt who knelt on the banks of the Nile to fill their red ...
(Date:5/26/2016)... ... May 26, 2016 , ... Workrite ... sales leadership and to further develop their rapidly expanding portfolio of customer and ... with a concentration in Marketing and an M.B.A. with concentration in management from ...
(Date:5/26/2016)... ... , ... May 2016 – Lips may be a central feature on our ... numbers of clients now ask about lip plumping and primping techniques and want tips ... Advanced Dermatology P.C. , The trend is a national one, with 2.4 ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... CHESTERFIELD, Va. , May 25, 2016 /PRNewswire/ ... next-generation sequencing test for wounds and infections. This ... ALL parasites, and select viruses. The test requires ... area. David G. Bostwick ... molecular testing to facilitate wound healing: "We are ...
(Date:5/25/2016)... 2016 ReportsnReports.com adds "Chronic ... that provides an overview on therapeutic pipeline of ... stages, therapeutics assessment by drug target, mechanism of ... type, along with latest updates, and featured news ... involved in the therapeutic development for Chronic Cough ...
(Date:5/24/2016)...   , Study met ... bowel cleansing and superiority in , ... of the ascending colon   ... Norgine B.V. today announced new positive data from the phase ... preparation) versus standard 2 litre PEG with ascorbate. The study met ...
Breaking Medicine Technology: